AUTHOR=Toriyama Manami , Rizaldy Defri , Nakamura Motoki , Atsumi Yukiko , Toriyama Michinori , Fujita Fumitaka , Okada Fumihiro , Morita Akimichi , Itoh Hiroshi , Ishii Ken J. 

TITLE=Dendritic cell proliferation by primary cilium in atopic dermatitis

JOURNAL=Frontiers in Molecular Biosciences

VOLUME=10

YEAR=2023

URL=https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2023.1149828

DOI=10.3389/fmolb.2023.1149828

ISSN=2296-889X

ABSTRACT=<p><bold>Introduction:</bold> Atopic dermatitis (AD) is a common allergic eczema that affects up to 10% of adults in developed countries. Immune cells in the epidermis, namely, Langerhans cells (LCs), contribute to the pathogenesis of AD, although their exact role(s) in disease remain unclear.</p><p><bold>Methods:</bold> We performed immunostaining on human skin and peripheral blood mononuclear cells (PBMCs) and visualized primary cilium.</p><p><bold>Result and discussion:</bold> We show that human dendritic cells (DCs) and LCs have a previously unknown primary cilium-like structure. The primary cilium was assembled during DC proliferation in response to the Th2 cytokine GM-CSF, and its formation was halted by DC maturation agents. This suggests that the role of primary cilium is to transduce proliferation signaling. The platelet-derived growth factor receptor alpha (PDGFRα) pathway, which is known for transducing proliferation signals in the primary cilium, promoted DC proliferation in a manner dependent on the intraflagellar transport (IFT) system. We also examined the epidermal samples from AD patients, and observed aberrantly ciliated LCs and keratinocytes in immature and proliferating states. Our results identify a potential relationship between the primary cilium and allergic skin barrier disorders, and suggest that targeting the primary cilium may contribute to treating AD.</p>